| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Alimera Sciences Inc (NASDAQ: ALIM)
ALIM Technical Analysis
5
| As on 9th Jun 2023 ALIM SHARE Price closed @ 2.50 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.42 & Strong Sell for SHORT-TERM with Stoploss of 4.69 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ALIMSHARE Price
| Open | 2.51 | Change | Price | % |
| High | 2.61 | 1 Day | -0.08 | -3.10 |
| Low | 2.47 | 1 Week | -0.25 | -9.09 |
| Close | 2.50 | 1 Month | 0.58 | 30.21 |
| Volume | 88159 | 1 Year | -2.13 | -46.00 |
| 52 Week High 7.70 | 52 Week Low 1.35 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ALIM Daily Charts |
ALIM Intraday Charts |
Whats New @ Bazaartrend |
ALIM Free Analysis |
|
|
ALIM Important Levels Intraday
| RESISTANCE | 2.77 |
| RESISTANCE | 2.68 |
| RESISTANCE | 2.63 |
| RESISTANCE | 2.58 |
| SUPPORT | 2.42 |
| SUPPORT | 2.37 |
| SUPPORT | 2.32 |
| SUPPORT | 2.23 |
ALIM Forecast April 2024
| 4th UP Forecast | 4.16 |
| 3rd UP Forecast | 3.63 |
| 2nd UP Forecast | 3.3 |
| 1st UP Forecast | 2.97 |
| 1st DOWN Forecast | 2.03 |
| 2nd DOWN Forecast | 1.7 |
| 3rd DOWN Forecast | 1.37 |
| 4th DOWN Forecast | 0.84 |
ALIM Weekly Forecast
| 4th UP Forecast | 4.14 |
| 3rd UP Forecast | 3.61 |
| 2nd UP Forecast | 3.29 |
| 1st UP Forecast | 2.96 |
| 1st DOWN Forecast | 2.04 |
| 2nd DOWN Forecast | 1.71 |
| 3rd DOWN Forecast | 1.39 |
| 4th DOWN Forecast | 0.86 |
ALIM Forecast2024
| 4th UP Forecast | 15.22 |
| 3rd UP Forecast | 11.14 |
| 2nd UP Forecast | 8.62 |
| 1st UP Forecast | 6.1 |
| 1st DOWN Forecast | -1.1 |
| 2nd DOWN Forecast | -3.62 |
| 3rd DOWN Forecast | -6.14 |
| 4th DOWN Forecast | -10.22 |
Alimera Sciences Inc ( NASDAQ USA Symbol : ALIM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ALIM Business Profile
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia. Address: 6120 Windward Parkway, Alpharetta, GA, United States, 30005
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service